Skip to main content

Type 1 diabetes and glucose control during labour and delivery

An update on diabetes management during labour and delivery in women with type 1 diabetes, focusing on insulin administration, carbohydrate supply, and the use of diabetes technology.

Read more

Editor's Choice

GLP-1 RAs could be repurposed for alcohol use disorder

GLP-1 receptor agonists may reduce the risk for hospitalization due to alcohol use disorder.

Extreme euglycemic ketoacidosis managed with hemodialysis

A patient with pancreatogenic diabetes developed extreme, life-threatening EDKA following re-exposure to an SGLT2 inhibitor and alcohol excess. Early renal replacement therapy was successful.

Diabetes treatments reduce asthma attack risk

Metformin significantly reduces asthma exacerbations, and the effect is greater still with add-on glucagon-like peptide-1 receptor agonists.

Growth hormone-releasing hormone in diabetes and metabolism

Explore the role of GHRH in metabolism, via the GHRH/GH/IGF-1 axis and extrapituitary effects, and the potentially beneficial effects of GHRH analogs for the treatment of metabolic diseases.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more

Using CGM to optimize type 2 diabetes management with non-intensive insulin treatment in primary care

With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report. 

Supported by:
  • Abbott Diabetes Care
Prof. Samuel Seidu
Developed by: Adis
Listen now

Case Studies

Extreme euglycemic ketoacidosis managed with hemodialysis

A patient with pancreatogenic diabetes developed extreme, life-threatening EDKA following re-exposure to an SGLT2 inhibitor and alcohol excess. Early renal replacement therapy was successful.

Use of GLP-1 agonists in patients with a Fontan circulation

A deep dive into eight cases of patients with a Fontan circulation who were prescribed GLP-1 agonists for obesity or diabetes. Find out if the treatments were effective, and what effects they had on patient comorbidities and safety outcomes. 

Mild familial partial lipodystrophy in a patient with a lamin gene mutation

A 38-year-old woman underwent genetic testing for suspected Brugada syndrome, but a missense mutation in the LMNA gene and the presence of suggestive traits led to a diagnosis of familial partial lipodystrophy type 2.

Episode 10: Disease-modifying therapy for type 1 diabetes

Reducing the burden of type 1 diabetes

Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.

Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.

Prof. Chantal Mathieu
Listen now

Current Reviews

Is Web-Based Diabetes Training Effective or Ineffective on the Quality of Life of Individuals with Type 2 Diabetes Mellitus?: A Systematic Review

Diabetes mellitus is called as the “pandemic of the era” due to its rising prevalence. Since it is a disease that affects all spheres of life, it has an impact on the quality of life of individuals. This systematic review aims to examine the …

Tipping the balance in autoimmunity: are regulatory t cells the cause, the cure, or both?

Regulatory T cells (Tregs) are a specialized subgroup of T-cell lymphocytes that is crucial for maintaining immune homeostasis and preventing excessive immune responses. Depending on their differentiation route, Tregs can be subdivided into …

Effects of quercetin on polycystic ovary syndrome in animal models: a systematic review and meta-analysis

Quercetin, a natural compound, is a flavonoid compound. Its molecular formula is C15H10O7, and its chemical name is 4 h-1-benzopyran-4-one, 2-(3,4-dihydroxy phenyl), 3,5,7trihydroxy-flavone. Quercetin is an effective ingredient in dietary …

Ranking the dietary interventions by their effectiveness in the management of polycystic ovary syndrome: a systematic review and network meta-analysis

Polycystic ovarian syndrome (PCOS) is one of the most common endocrine diseases in women of reproductive age. Depending on the population studied and the diagnostic criteria used, prevalence ranges from 5 to 18%. [ 1 ]. The Rotterdam Criteria …

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.

Developed by: Springer Medicine
Read more

CME & eLearning

Videos | Case Scenarios | Infographics (Link opens in a new window)

1.0 AMA PRA Category 1 Credit(s)

Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.

Supported by:
  • Abbott
Developed by: Springer Healthcare IME

Tweetorials | Vodcasts | Infographics (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)

Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.

Supported by:
  • Abbott
Developed by: Springer Healthcare IME

Vodcasts | Case Scenarios (Link opens in a new window)

Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S
Developed by: Springer Healthcare IME

Further Reading

The Michigan Collaborative for Type 2 Diabetes (MCT2D): Development and implementation of a statewide collaborative quality initiative

Type 2 diabetes (T2D) is a common, costly, and disabling chronic disease that affects 11% of adults in the United States [ 1 ]. Its most common complications include atherosclerotic cardiovascular disease (ASCVD), heart failure, chronic kidney …

Navigating outpatient care of patients with type 2 diabetes after hospital discharge - a qualitative longitudinal study

Care transition is defined as “the movement patients make between healthcare practitioners and settings as their condition and care needs change in the course of a chronic or acute illness” [ 1 ]. The transition from hospital to outpatient care is …

Service quality: perspective of people with type 2 diabetes mellitus and hypertension in rural and urban public primary healthcare centers in Iran

Diabetes and hypertension, recognized as major contributors to premature mortality, stand as primary risk factors for heart attacks, strokes, and kidney diseases [ 1 , 2 ]. Diabetes, in particular, may result in blindness and lower limb amputations …

Diabetic kidney disease screening status and related factors: a cross-sectional study of patients with type 2 diabetes in six provinces in China

Diabetic Kidney Disease (DKD) is caused by diabetes mellitus, increased blood glucose levels. Approximately 40% of people with diabetes may develop DKD [ 1 – 4 ]. Studies in the United States have shown that DKD has accounted for nearly half of all …

Related topics

Type 1 diabetes and glucose control during labour and delivery

An update on diabetes management during labour and delivery in women with type 1 diabetes, focusing on insulin administration, carbohydrate supply, and the use of diabetes technology.

Read more